Terms: = Head and neck cancer AND SOX2, MGC2413, 6657, ENSG00000181449, MCOPS3, P48431, ANOP3 AND Clinical Outcome
12 results:
1. Differential expression of ABCB1, ABCG2, and KLF4 as putative indicators for paclitaxel resistance in human epithelial type 2 cells.
Duz MB; Karatas OF
Mol Biol Rep; 2021 Feb; 48(2):1393-1400. PubMed ID: 33506275
[TBL] [Abstract] [Full Text] [Related]
2. Chemotherapeutic resistance of head and neck squamous cell carcinoma is mediated by EpCAM induction driven by IL-6/p62 associated Nrf2-antioxidant pathway activation.
Noman ASM; Parag RR; Rashid MI; Islam S; Rahman MZ; Chowdhury AA; Sultana A; Jerin C; Siddiqua A; Rahman L; Nayeem J; Akther S; Baidya S; Shil RK; Rahman M; Shirin A; Mahmud R; Hossain SMI; Sumi SA; Chowdhury A; Basher SB; Hasan A; Bithy S; Aklima J; Chowdhury N; Hasan MN; Banu T; Chowdhury S; Hossain MM; Yeger H; Farhat WA; Islam SS
Cell Death Dis; 2020 Aug; 11(8):663. PubMed ID: 32814771
[TBL] [Abstract] [Full Text] [Related]
3. High Expression of EpCAM and sox2 is a Positive Prognosticator of clinical outcome for head and neck Carcinoma.
Baumeister P; Hollmann A; Kitz J; Afthonidou A; Simon F; Shakhtour J; Mack B; Kranz G; Libl D; Leu M; Schirmer MA; Canis M; Belka C; Zitzelsberger H; Ganswindt U; Hess J; Jakob M; Unger K; Gires O
Sci Rep; 2018 Oct; 8(1):14582. PubMed ID: 30275505
[TBL] [Abstract] [Full Text] [Related]
4. Effect of 3q oncogenes SEC62 and sox2 on lymphatic metastasis and clinical outcome of head and neck squamous cell carcinomas.
Bochen F; Adisurya H; Wemmert S; Lerner C; Greiner M; Zimmermann R; Hasenfus A; Wagner M; Smola S; Pfuhl T; Bozzato A; Al Kadah B; Schick B; Linxweiler M
Oncotarget; 2017 Jan; 8(3):4922-4934. PubMed ID: 28002801
[TBL] [Abstract] [Full Text] [Related]
5. Gli1, a potential regulator of esophageal cancer stem cell, is identified as an independent adverse prognostic factor in esophageal squamous cell carcinoma.
Yang Z; Cui Y; Ni W; Kim S; Xuan Y
J Cancer Res Clin Oncol; 2017 Feb; 143(2):243-254. PubMed ID: 27680978
[TBL] [Abstract] [Full Text] [Related]
6. A Limited Immunohistochemical Panel to Distinguish Basal Cell Carcinoma of Cutaneous Origin From Basaloid Squamous Cell Carcinoma of the head and neck.
Villada G; Kryvenko ON; Campuzano-Zuluaga G; Kovacs C; Chapman J; Gomez-Fernandez C
Appl Immunohistochem Mol Morphol; 2018 Feb; 26(2):126-131. PubMed ID: 27438511
[TBL] [Abstract] [Full Text] [Related]
7. Loss of sox2 expression induces cell motility via vimentin up-regulation and is an unfavorable risk factor for survival of head and neck squamous cell carcinoma.
Bayo P; Jou A; Stenzinger A; Shao C; Gross M; Jensen A; Grabe N; Mende CH; Rados PV; Debus J; Weichert W; Plinkert PK; Lichter P; Freier K; Hess J
Mol Oncol; 2015 Oct; 9(8):1704-19. PubMed ID: 26040981
[TBL] [Abstract] [Full Text] [Related]
8. A three-gene signature and clinical outcome in esophageal squamous cell carcinoma.
Sun LL; Wu JY; Wu ZY; Shen JH; Xu XE; Chen B; Wang SH; Li EM; Xu LY
Int J Cancer; 2015 Mar; 136(6):E569-77. PubMed ID: 25220908
[TBL] [Abstract] [Full Text] [Related]
9. sox2 expression in hypopharyngeal, laryngeal, and sinonasal squamous cell carcinoma.
González-Márquez R; Llorente JL; Rodrigo JP; García-Pedrero JM; Álvarez-Marcos C; Suárez C; Hermsen MA
Hum Pathol; 2014 Apr; 45(4):851-7. PubMed ID: 24656096
[TBL] [Abstract] [Full Text] [Related]
10. Expression of cancer stem cell markers is more frequent in anaplastic thyroid carcinoma compared to papillary thyroid carcinoma and is related to adverse clinical outcome.
Yun JY; Kim YA; Choe JY; Min H; Lee KS; Jung Y; Oh S; Kim JE
J Clin Pathol; 2014 Feb; 67(2):125-33. PubMed ID: 23986551
[TBL] [Abstract] [Full Text] [Related]
11. Podoplanin and sox2 expression in esophageal squamous cell carcinoma after neoadjuvant chemo-radiotherapy.
Saigusa S; Mohri Y; Ohi M; Toiyama Y; Ishino Y; Okugawa Y; Tanaka K; Inoue Y; Kusunoki M
Oncol Rep; 2011 Nov; 26(5):1069-74. PubMed ID: 21811761
[TBL] [Abstract] [Full Text] [Related]
12. Oct3/4 and sox2 are significantly associated with an unfavorable clinical outcome in human esophageal squamous cell carcinoma.
Wang Q; He W; Lu C; Wang Z; Wang J; Giercksky KE; Nesland JM; Suo Z
Anticancer Res; 2009 Apr; 29(4):1233-41. PubMed ID: 19414369
[TBL] [Abstract] [Full Text] [Related]
